Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (ACLX), DENTSPLY SIRONA (XRAY) and Personalis (PSNL)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Arcellx Inc (ACLX – Research Report), DENTSPLY SIRONA (XRAY – Research Report) and Personalis (PSNL – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Arcellx Inc (ACLX)
Needham analyst Gil Blum maintained a Hold rating on Arcellx Inc today. The company’s shares closed last Thursday at $113.88.
According to TipRanks.com, Blum is a 4-star analyst with an average return of
Arcellx Inc has an analyst consensus of Hold, with a price target consensus of $112.67, a -1.0% downside from current levels. In a report released today, TipRanks – OpenAI also upgraded the stock to Hold with a $122.00 price target.
See the top stocks recommended by analysts >>
DENTSPLY SIRONA (XRAY)
In a report released today, David Saxon from Needham maintained a Hold rating on DENTSPLY SIRONA. The company’s shares closed last Thursday at $12.71.
According to TipRanks.com, Saxon is a 1-star analyst with an average return of
DENTSPLY SIRONA has an analyst consensus of Hold, with a price target consensus of $13.86, which is an 8.2% upside from current levels. In a report released today, TipRanks – Anthropic also upgraded the stock to Hold with a $12.00 price target.
Personalis (PSNL)
In a report released today, Michael Matson from Needham maintained a Buy rating on Personalis, with a price target of $12.00. The company’s shares closed last Thursday at $9.03.
According to TipRanks.com, Matson is a 2-star analyst with an average return of
Currently, the analyst consensus on Personalis is a Strong Buy with an average price target of $11.83.
